Clinical Trial Update: To Evaluate the Safety and Efficacy of ADP-TILIL7 in Patients With Locally Advanced or Metastatic Melanoma [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating the safety and potential efficacy of ADP-TILIL7 in patients with locally advanced or metastatic melanoma, currently recruiti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• ADP-TILIL7 (ADP-TILIL7)

Snippet

Sponsor: Inge Marie Svane | Conditions: Melanoma Stage III, Melanoma Stage IV | Phase 1 | Status: RECRUITING